We are excited to be presenting our newest Enzyme Activity Assay for newborn screening of Tay-Sachs and Sandhoff diseases at the 2024 WORLD Symposium in San Diego.
Stop by on Tuesday between 3-5 PM for Poster Session II, where we will be presenting our poster: “Tandem mass spectrometric enzyme activity assay for simultaneous detection of Tay-Sachs and Sandhoff diseases in dried blood spots for newborn screening.”
A sincere thank you to the National Tay-Sachs & Allied Diseases Association and the families for your great support!
This work would not be possible without the support of:
ARCHIMEDlife Medical Laboratories
CoMotion at University of Washington
SIO Gene Therapies
Taysha Gene Therapies
National Institutes of Health (NIH), Award Number 1R41HD109092-01
#NIH #NTSAD #SIOGeneTherapies #TayshaGeneTherapies #TaySachs #Sandhoff #GM2Gangliosidosis #NewbornScreening #EnzymeActivity #CoMotionSupported #ARCHIMEDlife